Recent research reveals a troubling rise in obesity-related cancer deaths in the US, highlighting obesity as a significant risk factor for various cancers.

Donnington pharmacy superintendent Nigel Dugmore said the online weight loss jab industry is a "ticking time bomb" due to the ...

Rajni Gupta, 56, underwent the procedure on July 11 but passed away on July 15 due to complications from the surgery that ...

Patients prescribed drugs to help them lose weight may experience a rebound in weight gain after halting their prescription, ...

Portion sizes in the US are famously large, whether in restaurant meals or packaged foods, unlike their European or Asian ...

For decades now, obesity has been defined by a number on a scale or where you land on the body mass index (BMI) measure. But ...

Patients prescribed drugs to help them lose weight may experience a rebound in weight gain after halting their prescription, ...

In just a few years, weight-loss drugs like Ozempic and Wegovy have become a global sensation. They promise to do something ...

GLP-1 drugs like Ozempic and Mounjaro helped men with low testosterone raise their levels without hormone replacement in a ...

GLP-1 drugs came out in 2005 as a Type 2 diabetes treatment. But in recent years their popularity for weight loss -- and the cost -- has taken off.

GLP-1 drugs like semaglutide (Ozempic) and tirzepatide (Mounjaro) may shrink fat, but also crucial muscle mass, with little evidence of improving cardiorespiratory fitness, researchers say.

More data, this time from a large observational study, are bolstering the idea that glucagon-like peptide-1 (GLP-1) receptor agonists offer neuroprotective and cerebrovascular benefits beyond what can ...